Asset Publisher

Ministry of Health Coordinates with the Relevant Authorities in Oman and GCC regarding USFDA Warning

Ministry of Health Coordinates with the Relevant Authorities in Oman and GCC regarding USFDA Warning

Ministry of Health Coordinates with the Relevant Authorities in Oman and GCC regarding USFDA Warning

16/9/2019

 

The Ministry of Health has paid attention to the warning issued by the U.S. Food and Drug Administration (FDA) on detecting a probable cancer-causing chemical in Ranitidine medications, sold under the trade name Zantac to treat stomach acid and ulcers. FDA is investigating whether the low levels of N-nitrosodimethylamine (NDMA) found in the drug pose a health risk to patients.

For the safety and health of the Sultanate’s people, the Ministry of Health has thus taken the needed precautionary measures with all concerned authorities to ensure the absence of the dangerous substances in the medication ingredients marketed in the Sultanate. The Ministry is closely following up any updates in this regard.



Comments